Initia Nova Paramedical Exams &Testing North Charleston, SC - 29405

Initia Nova Paramedical Exams &Testing is categorized under Inspection Services in North Charleston, SC and active since 2010.

Initia Nova Paramedical Exams &Testing was established in 2010, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Inspection Services business, which does work in the B2B market, and is classified as a Inspection Services, under code number 561990 by the NAICS.

If you are seeking more information, feel free to contact at the company’s single location by writing to 1847 Doscher Avenue, North Charleston, South Carolina SC 29405 or by phoning (843) 478-5048. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Initia Nova Paramedical Exams &Testing
Address: 1847 Doscher Avenue, North Charleston, South Carolina 29405
Phone Number: (843) 478-5048
Annual Revenue (USD): $50.000 to $99.999
Founded: 2010
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Inspection Services
SIC Code: 7389
NAICS Code: 561990
Share This Business:

Initia Nova Paramedical Exams &Testing was started in 2010 to provide professional Inspection Services under the SIC code 7389 and NAICS code 561990. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact for inquiries that concern Initia Nova Paramedical Exams &Testing by calling the company number (843) 478-5048, as your correspondence is most welcome. Additionally, the physical location of the single location of Initia Nova Paramedical Exams &Testing can be found at the coordinates as well as the street address 1847 Doscher Avenue in North Charleston, South Carolina 29405.

For its online presence, you may visit Initia Nova Paramedical Exams &Testing’s website at and engage with its social media outlets through on Twitter and on Facebook.